Everything you need to know to do business in the country Key economic sector data and exclusive interviews from regional leaders China is the third largest pharmaceutical market in the world and slated to become the second largest ahead of Japan by 2015. This phenomenal growth can be traced to favorable government policies towards healthcare and innovation, driving a 20%+ compounded annual growth rate. To date, the 12th Five Year plan has earmarked $1.9 billion (USD) for new drug research and development. Written after exclusive interviews with China’s decision makers from local and multinational companies, manufacturers, distributors, experts, legislators, this is a unique resource for those looking beyond figures. Contributors include: CPEA, Beijing Pharma & Biotech Center, ABO, Keller Pharma Consultancy, BIOCOM China Consulting, and many more. PDF Report: $149.00. From Focus Reports, Ltd., Pharmaceutical Executive and Pharmaceutical Executive Global Digest Focus Reports serves business professionals in the Pharmaceutical industry. The country reports offer a snapshot of the challenges and issues faced by an industry through the voice and insight of the decision makers at government, legislative and corporate levels. They are based on exclusive interviews conducted by our staff.